HowShorted

How shorted is CG Oncology, Inc.?

More shorted than 90% of the 2,877 ranked US companies

14.03%
of shares outstanding reported short · settlement date 31 Jul 2026
vs previous report
−0.31
5 reports (~10 weeks)
+3.16
Aggregate net short position time series for CG Oncology, Inc.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
31 Jul 202614.03%−0.31
15 Jul 202614.34%+0.05
30 Jun 202614.29%+1.78
15 Jun 202612.51%+0.89
29 May 202611.62%+0.75
15 May 202610.87%−0.05
30 Apr 202610.92%−0.37
15 Apr 202611.29%−1.19
31 Mar 202612.48%−0.02
13 Mar 202612.50%+1.49
27 Feb 202611.01%−0.76
13 Feb 202611.77%+0.31
30 Jan 202611.46%−0.18
15 Jan 202611.64%−4.38
31 Dec 202516.02%−0.28
15 Dec 202516.30%−0.70
28 Nov 202517.00%+0.63
14 Nov 202516.37%+0.01
31 Oct 202516.36%+0.33
15 Oct 202516.03%+0.30
30 Sep 202515.73%+1.29
15 Sep 202514.44%+1.02
29 Aug 202513.42%−0.13
15 Aug 202513.55%−0.89
31 Jul 202514.44%–

Frequently asked questions

How shorted is CG Oncology, Inc. right now?
14.03% of CG Oncology, Inc.'s (CGON) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.